Trademark search for:

OMNIVIUM PHARMA

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results

Also check across:

USPTO Filing History

Key events recorded for this trademark application

2021-07-21 — Application filed
2021-07-24 — Application filed
2021-09-22 — Application filed
2022-04-14 — Assigned to examiner
2022-04-21 — Final disposition recorded
2022-04-21 — Final disposition recorded
2022-04-21 — Final disposition recorded
2022-08-24 — Office action issued
2022-08-24 — Correspondence received in law office
2022-08-24 — Teas/email correspondence entered
2022-08-25 — Examiners amendment -written
2022-08-25 — Examiners amendment e-mailed
2022-08-25 — Notification of examiners amendment e-mailed
2022-08-25 — Examiner's amendment entered
2022-08-25 — Approved for pub - principal register
2022-09-07 — Notification of notice of publication e-mailed
2022-09-27 — Published for opposition
2022-09-27 — Official gazette publication confirmation e-mailed
2022-11-22 — Noa e-mailed - sou required from applicant
2023-05-22 — Sou teas extension received
2023-05-22 — Sou extension 1 filed
2023-05-22 — Sou extension 1 granted
2023-05-24 — Notice of approval of extension request e-mailed
2023-11-22 — Sou teas extension received
2023-11-22 — Sou extension 2 filed
2023-11-22 — Sou extension 2 granted
2023-11-24 — Notice of approval of extension request e-mailed
2024-05-20 — Sou teas extension received
2024-05-20 — Sou extension 3 filed
2024-05-20 — Sou extension 3 granted
2024-05-21 — Notice of approval of extension request e-mailed
2024-11-18 — Sou teas extension received
2024-11-18 — Sou extension 4 filed
2024-12-04 — Sou extension 4 granted
2024-12-04 — Notice of approval of extension request e-mailed
2025-05-11 — Sou extension 5 filed
2025-05-12 — Sou teas extension received
2025-09-29 — Case assigned to intent to use paralegal
2025-09-29 — Sou extension 5 granted
2025-09-30 — Notice of approval of extension request e-mailed
2025-12-22 — Application abandoned
2025-12-22 — Application abandoned
2025-12-22 — Final status recorded

Owner Information

Omnivium Pharmaceuticals LLC
Rahway , NJ

Filing Details

Filing Date:
2021-07-21

Status Date:
2025-12-22

Category:
Science & Technology Services

Filing Year:
2021

OMNIVIUM PHARMA

USPTO Filing History

Owner Information

Correspondent

Filing Details